NEURONETICS INC
STIMNASDAQTrading Snapshot
- Day Range
- $3.15 – $3.22
- 52-Week Range
- $0.80 – $4.31
- Volume
- $3.69B
- Avg Volume
- $3.56B
- Shares Outstanding
- 69.6M
- Next Earnings
- Sep 1, 2026
Fundamentals Snapshot
- Annual Revenue
- $151M
- Last Q Revenue
- $34M
- P/E Ratio
- —
- P/S Ratio
- 1.0x
- EPS (TTM)
- $-0.55
- Dividend Yield
- —
Why Investors Own STIM
- ✓High-growth profile — revenue up +46.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 75% gross margin and 24% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About NEURONETICS INC
A company profile for NEURONETICS INC isn’t available yet — check back soon.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
What's going on in today's session
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Here are the top movers in Tuesday's session.
Looking for insights into the US markets in the middle of the day on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Traders are paying attention to the gapping stocks in Tuesday's session.
The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release, Q2 earnings
Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript
Neuronetics, Inc. (STIM) Q2 2026 Earnings Call August 11, 2026 8:30 AM EDTCompany ParticipantsDaniel Reuvers - CEO, President & DirectorNir Naor -...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's pre-market session. The market value of their outstanding shares is at $43.4 million. Organigram Global (NASDAQ:OGI)